Flossbach Von Storch Ag Danaher Corp Transaction History

Flossbach Von Storch Ag

$22.9 Billion
Q1 2024

A detailed history of Flossbach Von Storch Ag transactions in Danaher Corp stock. As of the latest transaction made, Flossbach Von Storch Ag holds 4,260,084 shares of DHR stock, worth $1.09 Billion. This represents 4.64% of its overall portfolio holdings.

Number of Shares

4,260,084

Previous 4,601,351 7.42%

Holding current value

$1.09 Billion

Previous $1.06 Billion 0.06%

% of portfolio

4.64%

Previous 4.87%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 06, 2024	SELL	$224.58 - $256.19 $76.6 Million - $87.4 Million	-341,267 Reduced 7.42%	4,260,084 $1.06 Billion
Q4 2023 Jan 31, 2024	BUY	$185.1 - $233.13 $15.3 Million - $19.3 Million	82,672 Added 1.83%	4,601,351 $1.06 Billion
Q3 2023 Oct 27, 2023	BUY	$233.08 - $265.59 $1.71 Million - $1.94 Million	7,322 Added 0.16%	4,518,679 $1.12 Billion
Q2 2023 Aug 02, 2023	BUY	$224.99 - $256.14 $282 Million - $321 Million	1,252,274 Added 38.42%	4,511,357 $1.08 Billion
Q1 2023 May 03, 2023	BUY	$239.75 - $277.0 $168 Million - $194 Million	699,932 Added 27.35%	3,259,083 $821 Million

Q4 2022 Feb 06, 2023	BUY	$241.42 - $282.29 $4.87 Million - $5.7 Million	20,188 Added 0.8%	2,559,151 $679 Million
Q3 2022 Nov 14, 2022	SELL	$247.06 - $1507.4 $51 Million - $311 Million	-206,499 Reduced 7.52%	2,538,963 $656 Million
Q2 2022 Aug 10, 2022	BUY	$237.11 - $299.66 $69.3 Million - $87.6 Million	292,265 Added 11.91%	2,745,462 $696 Million
Q1 2022 May 11, 2022	BUY	$257.27 - $315.76 $256 Million - $314 Million	994,835 Added 68.22%	2,453,197 $720 Million
Q4 2021 Feb 04, 2022	BUY	$292.08 - $329.01 $102 Million - $115 Million	348,736 Added 31.43%	1,458,362 $480 Million
Q3 2021 Nov 04, 2021	BUY	$272.21 - $332.43 $1.78 Million - $2.17 Million	6,522 Added 0.59%	1,109,626 $338 Million
Q2 2021 Aug 02, 2021	SELL	$225.08 - $271.69 $9.41 Million - $11.4 Million	-41,816 Reduced 3.65%	1,103,104 $296 Million
Q1 2021 May 04, 2021	BUY	$212.38 - $245.9 $76.1 Million - $88.2 Million	358,535 Added 45.59%	1,144,920 $258 Million
Q4 2020 Feb 09, 2021	SELL	$212.5 - $245.46 $52.4 Million - $60.6 Million	-246,800 Reduced 23.89%	786,385 $175 Million
Q3 2020 Nov 05, 2020	SELL	$177.16 - $215.33 $9.37 Million - $11.4 Million	-52,866 Reduced 4.87%	1,033,185 $222 Million
Q2 2020 Aug 10, 2020	SELL	$128.7 - $176.83 $2.41 Million - $3.31 Million	-18,735 Reduced 1.7%	1,086,051 $192 Million
Q1 2020 May 11, 2020	SELL	$121.39 - $169.05 $41.5 Million - $57.8 Million	-342,019 Reduced 23.64%	1,104,786 $153 Million
Q4 2019 Feb 11, 2020	BUY	$133.47 - $153.48 $14.1 Million - $16.2 Million	105,564 Added 7.87%	1,446,805 $222 Million
Q3 2019 Nov 08, 2019	BUY	$135.4 - $146.47 $9.31 Million - $10.1 Million	68,780 Added 5.41%	1,341,241 $194 Million
Q2 2019 Aug 06, 2019	SELL	$124.88 - $143.73 $60.3 Million - $69.4 Million	-482,850 Reduced 27.51%	1,272,461 $182 Million
Q1 2019 May 02, 2019	SELL	$97.62 - $132.29 $325 Million - $441 Million	-3,330,189 Reduced 65.48%	1,755,311 $232 Million
Q4 2018 Feb 05, 2019	SELL	$94.85 - $109.54 $61.1 Million - $70.6 Million	-644,330 Reduced 11.25%	5,085,500 $524 Million
Q3 2018 Nov 05, 2018	BUY	$98.13 - $108.9 $17.7 Million - $19.6 Million	180,025 Added 3.24%	5,729,830 $623 Million
Q2 2018 Aug 08, 2018	SELL	$96.1 - $103.24 $6.21 Million - $6.67 Million	-64,640 Reduced 1.15%	5,549,805 $548 Million
Q1 2018 May 04, 2018	SELL	$92.16 - $103.8 $106 Million - $119 Million	-1,150,056 Reduced 17.0%	5,614,445 $550 Million
Q4 2017 Feb 07, 2018	SELL	$85.26 - $94.62 $1.06 Million - $1.18 Million	-12,420 Reduced 0.18%	6,764,501 $628 Million
Q3 2017 Nov 09, 2017	BUY	$79.29 - $88.45 $537 Million - $599 Million	6,776,921	6,776,921 $581 Million

Others Institutions Holding DHR

# of Institutions

2,369

Shares Held

559M

Call Options Held

3.54M

Put Options Held

3.99M

View Full List

About DANAHER CORP

Ticker DHR
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 727,963,008
Market Cap $187B
Description
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...

More about DHR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Flossbach Von Storch Ag, based on Form 13F filings with the SEC.

News

Stay updated on Flossbach Von Storch Ag with notifications on news.

Account

Flossbach Von Storch Ag Danaher Corp Transaction History